Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$22M Sell
171,186
-565
-0.3% -$66.1K 1.73% 14
2026
Q1
$20.7M Buy
171,751
+784
+0.5% +$90.5K 1.75% 14
2025
Q4
$18M Buy
170,967
+1,520
+0.9% +$143K 1.46% 18
2025
Q3
$14.2M Buy
169,447
+1,658
+1% +$137K 1.18% 26
2025
Q2
$13.3M Sell
167,789
-135
-0.1% -$10.7K 1.21% 27
2025
Q1
$15.1M Buy
167,924
+2,567
+2% +$240K 1.46% 23
2024
Q4
$16.4M Buy
165,357
+2,621
+2% +$270K 1.58% 14
2024
Q3
$18.5M Sell
162,736
-2,270
-1% -$270K 1.8% 13
2024
Q2
$20.4M Buy
165,006
+3,112
+2% +$401K 2.09% 9
2024
Q1
$21.4M Sell
161,894
-1,855
-1% -$229K 2.32% 9
2023
Q4
$17.9M Buy
163,749
+3,291
+2% +$342K 2.07% 10
2023
Q3
$16.5M Sell
160,458
-32,409
-17% -$3.49M 2.15% 11
2023
Q2
$22.3M Sell
192,867
-19,304
-9% -$2.19M 2.77% 8
2023
Q1
$22.6M Buy
212,171
+2,687
+1% +$290K 3.09% 5
2022
Q4
$23.2M Buy
209,484
+640
+0.3% +$65.4K 3.35% 5
2022
Q3
$18M Buy
208,844
+3,971
+2% +$354K 2.81% 8
2022
Q2
$18.7M Sell
204,873
-418
-0.2% -$37.1K 2.75% 7
2022
Q1
$16.8M Buy
205,291
+518
+0.3% +$40.8K 2.13% 14
2021
Q4
$15.7M Buy
204,773
+1,043
+0.5% +$83.1K 1.8% 23
2021
Q3
$15.3M Buy
203,730
+2,330
+1% +$177K 1.93% 20
2021
Q2
$15.7M Sell
201,400
-8,570
-4% -$637K 1.98% 18
2021
Q1
$15.4M Buy
209,970
+2,889
+1% +$213K 2.15% 19
2020
Q4
$16.2M Buy
207,081
+2,507
+1% +$192K 2.38% 16
2020
Q3
$16.2M Buy
204,574
+4,972
+2% +$389K 2.59% 13
2020
Q2
$14.7M Buy
199,602
+94
+0% +$7.08K 2.63% 13
2020
Q1
$14.6M Buy
199,508
+4,115
+2% +$323K 3.27% 9
2019
Q4
$17M Buy
195,393
+13,661
+8% +$1.12M 2.77% 7
2019
Q3
$14.6M Buy
181,732
+1,029
+0.6% +$82.5K 2.81% 7
2019
Q2
$14.5M Buy
180,703
+16,830
+10% +$1.29M 2.79% 8
2019
Q1
$13M Buy
163,873
+1,761
+1% +$132K 2.79% 9
2018
Q4
$11.8M Sell
162,112
-1,820
-1% -$128K 2.79% 11
2018
Q3
$11.1M Sell
163,932
-464
-0.3% -$29.6K 2.36% 13
2018
Q2
$9.52M Buy
164,396
+485
+0.3% +$27.4K 2.13% 18
2018
Q1
$8.52M Buy
163,911
+1,776
+1% +$95.9K 1.98% 23
2017
Q4
$8.71M Buy
162,135
+2,802
+2% +$155K 2.01% 21
2017
Q3
$9.73M Sell
159,333
-1,887
-1% -$114K 2.43% 16
2017
Q2
$9.86M Sell
161,220
-1,103
-0.7% -$67.1K 2.51% 13
2017
Q1
$9.84M Sell
162,323
-1,025
-0.6% -$62.2K 2.57% 16
2016
Q4
$9.18M Buy
163,348
+541
+0.3% +$31.7K 2.53% 15
2016
Q3
$9.7M Sell
162,807
-26
-0% -$1.52K 2.65% 13
2016
Q2
$8.95M Buy
162,833
+1,929
+1% +$103K 2.48% 16
2016
Q1
$8.12M Buy
160,904
+907
+0.6% +$44.4K 2.32% 20
2015
Q4
$8.06M Sell
159,997
-617
-0.4% -$31.1K 2.16% 20
2015
Q3
$7.57M Sell
160,614
-41,544
-21% -$2.21M 2.15% 20
2015
Q2
$11M Sell
202,158
-4,363
-2% -$245K 2.96% 8
2015
Q1
$11.3M Sell
206,521
-4,014
-2% -$227K 3% 4
2014
Q4
$11.8M Buy
210,535
+950
+0.5% +$52.9K 3.1% 7
2014
Q3
$11.9M Sell
209,585
-1,125
-0.5% -$63.2K 3% 7
2014
Q2
$11.6M Buy
210,710
+528
+0.3% +$28.8K 2.89% 7
2014
Q1
$11.4M Buy
210,182
+27,713
+15% +$1.44M 2.96% 7
2013
Q4
$8.71M Buy
182,469
+2,098
+1% +$95.9K 2.2% 14
2013
Q3
$8.19M Buy
180,371
+2,210
+1% +$101K 2.32% 10
2013
Q2
$7.9M Buy
+178,161
New +$7.96M 2.35% 12

Other funds holding MRK

J.M. Forbes & Co's MRK Position: Q2 2026 in Review

J.M. Forbes & Co reduced its Merck (MRK) stake by 0.33% in Q2 2026, selling an estimated $66.1K and leaving 171,186 shares worth $22M. The position accounts for 1.73% of the portfolio, ranked #14.

J.M. Forbes & Co first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $23.2M in Q4 2022. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • J.M. Forbes & Co held 171,186 shares of Merck worth $22M as of Q2 2026.
  • J.M. Forbes & Co sold 565 Merck shares in Q2 2026, an estimated $66.1K.
  • Merck made up 1.73% of J.M. Forbes & Co's portfolio in Q2 2026, its #14 holding.
  • J.M. Forbes & Co first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • J.M. Forbes & Co's Merck position peaked at $23.2M in Q4 2022.
  • 1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on J.M. Forbes & Co's 13F filing for Q2 2026, filed 20 Jul 2026.